Bridging the gap between advances in basic biology and chemistry and technological applications in the field of toxicity assessments, this book describes major areas of progress in the laboratory and clinic.
The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD).
Understanding the nature and role of endothelium-derived hyperpolarizing factor appears to be crucial in the quest for improved treatments for hypertension, diabetes, ischemia-reperfusion and other vascular disorders.
Open a Window into the Autonomic Nervous SystemQuantifying the amount of autonomic nervous system activity in an individual patient can be extremely important, because it provides a gauge of disease severity in a large number of diseases.
For two decades, Swine in the Laboratory: Surgery, Anesthesia, and Experimental Techniques has been the most respected practical technical guide for medical and veterinary researchers using swine as experimental animals.
This monograph was developed from a collection of papers that were origi- nally presented at a symposium entitled "e;Pathogenesis of Hypertension"e; held at the Henry Chauncy Conference Center, Princeton.
The third edition of Current Cardiovascular Drugs is designed to provide an updated practical compendium of current knowledge regarding cardiovascular drug therapy in a concise, easily readable format.
a comprehensive and real picture of the complexities of ischemic heart disease, both to the person who deals in day to day practice with its problems, as well as to the This book presents a comprehensive picture of is- chemic heart disease to those who, either as practition- student and resident who tries to develop firm concepts ers or students, deal with the varied facets of this com- regarding the varied states observed in this common plex subject.
In Atlas of Nuclear Cardiology, Doctors Dilsizian and Narula have worked together with over a dozen leading authorities to capture the most up-to-date and pertinent information in the field of nuclear cardiology.
In its third edition, the Atlas of Heart Failure provides a comprehensive up-to-date overview of normal cardiac function, the mechanisms of dysfunction in heart failure, and the therapeutic approaches that are available to manage the syndrome.
We are in the early years of a new millen- Tremendous interest is now focused on nium and atherosclerotic disease is now the characteristics of atherosclerotic thought to underlie more adult deaths plaques, as we recognize that many clinical than any other disease on the planet.
HE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR, or T"e;lCD,"e; is arguably the most technologically challenging type of therapy that physicians utilize today.
In this book, the importance and value of accurately assessing coronary stenosis morphology is reviewed, including recent thoughts regarding the pathogenetic mechanisms ascribed to angiographically assessed morphology, several new and potentially more accurate means of determining plaque composition and its relationship to stenosis morphology, and the latest hypotheses regarding interventional device selection.
For over a quarter of a century, echocardiography has made an unparalleled contribution to clinical cardiology as a major tool for real-time imaging of cardiac dynamics.
Angioplasty has completely transformed the treatment of coronary artery disease and is widely used, with more than 800,000 procedures performed worldwide per year.
Non-Invasive Imaging of Atherosclerosis is a primer, reference and review of some of the key features of current activities in the field of atherosclerosis.
The last five years have witnessed an increasing interest in the subject of transmyocardial laser revascularization (TMR) as illustrated by the number of abstracts presented at the meetings of the American Heart Association and the American College of Cardiology (Figure).
Despite recent advances in the diagnosis and treatment of various cardiac illnesses, including ischemic, valvular and cardiomyopathic disease, the most cost-effective means of employing laboratory testing and treatment modalities remains an issue in most practice settings.
